FEMASYS INC
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
FEMY$1.43+0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
Exhibits.
| Exhibit Number | Description of Document | Schedule/Form | Exhibit | Filing Date |
|---|---|---|---|---|
| 3.1 | Eleventh Amended and Restated Certificate of Incorporation of Femasys Inc. | Form 8-K | 3.1 | June 22, 2021 |
| 3.2 | Amended and Restated Bylaws of Femasys Inc. | Form 8-K | 3.2 | June 22, 2021 |
| 3.3 | First Amendment to the Amended and Restated Bylaws of Femasys Inc., dated as of March 29, 2023 | Form 8-K | 3.1 | March 30, 2023 |
| 4.2 | Form of Certificate of Common Stock | Form S-1 | 4.1 | May 14, 2021 |
| 4.3 | Form of indenture | Form S-3 | 4.3 | July 1, 2022 |
| 4.4 | Form of Pre-Funded Warrant | Form 8-K | 4.1 | April 20, 2023 |
| 4.5 | Form of Common Stock Warrant | Form 8-K | 4.2 | April 20, 2023 |
| 4.6 | Form of Placement Agent Warrant | Form 8-K | 4.3 | April 20, 2023 |
| 4.7 | Form of Series A Warrant | Form 8-K | 4.1 | November 15, 2023 |
| 4.8 | Underwriter Warrant | Form 8-K | 4.1 | June 2, 2025 |
| 4.9 | Underwriter Common Stock Purchase Warrant | Form 8-K | 4.1 | August 27, 2025 |
| 4.10 | Pre-Funded Common Stock Purchase Warrant | Form 8-K | 4.2 | August 27, 2025 |
| 4.11 | Common Stock Purchase Warrant | Form 8-K | 4.3 | August 27, 2025 |
| 4.12 | Form of Series A-1 Warrant | Form 8-K | 4.1 | November 7, 2025 |
| 4.13 | Form of Series B-1 Warrant | Form 8-K | 4.2 | November 7, 2025 |
| 4.14 | Form of Series C-1 Warrant | Form 8-K | 4.3 | November 7, 2025 |
| 10.1 | Femasys Inc. 2021 Equity Incentive Plan, and forms of agreements thereunder | Form S-1 | 10.3 | May 14, 2021 |
| 10.2 | Femasys Inc. 2021 Employee Stock Purchase Plan | Form S-1 | 10.4 | May 14, 2021 |
| 10.3 | Amended and Restated Employment Agreement, by and between Femasys Inc. and Kathy Lee-Sepsick | Form S-1/A | 10.6 | June 14, 2021 |
| 10.4 | Femasys Inc. Non-Employee Director Compensation Policy | Form S-1/A | 10.11 | June 14, 2021 |
| 10.5 | Form of Indemnification Agreement between Femasys Inc. and its directors and officers | Form S-1 | 10.12 | May 14, 2021 |
| 10.6 | Master Services Agreement and Statement of Work for consulting services, effective August 12, 2021, by and between Femasys Inc. and Bespoke Medical Affairs Solutions, LLC | Form 10-Q | 10.1 | November 12, 2021 |
| 10.7 | Employment Agreement, dated as of February 28, 2022, between Femasys Inc. and Dov Elefant | Form 8-K | 10.1 | February 24, 2022 |
| 10.8 | Form of Inducement Stock Option Agreement | Form 8-K | 10.2 | February 24, 2022 |
| 10.9 | Equity Purchase Agreement dated July 1, 2022, between Femasys Inc. and Piper Sandler & Co. | Form S-3 | 1.2 | July 1, 2022 |
| 10.10 | Purchase Agreement dated June 30, 2025, by and between Femasys Inc. and Alumni Capital LP. | Form S-3 | 10.1 | July 3, 2025 |
| 10.11 | Separation Agreement with Daniel Currie | Form 8-K | 10.1 | October 17, 2025 |
| 10.12 | Form of Senior Secured Convertible Note | Form 8-K | 10.2 | November 7, 2025 |
| 10.13 | Form of Securities Purchase Agreement dated November 3, 2025 between Femasys Inc. and the other parties thereto | Form 8-K | 10.1 | November 7, 2025 |
| 10.14* | Form of Registration Rights Agreement dated November 7, 2025 between Femasys Inc. and the other parties thereto | |||
| 19.1* | Insider Trading Policy | |||
| 23.1* | Consent of KPMG LLP | |||
| 24.1* | Power of Attorney (included on signature page) | |||
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||
| 32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||
| 101.INS* | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) | |||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | |||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||
| 104* | Cover Page Interactive Data File (formatted as inline XRBL and contained in Exhibit 101) | |||
- Filed herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.